Patent Assignment
Reel/Frame 025568/0888
Assignment of Assignor's Interest
Recorded: 2010-12-27
Pages: 7
Assignor
BIOSANTE PHARMACEUTICALS, INC.
Executed: 2010-11-15
Assignee
COLD GENESYS, INC.
2 NARBONNE, NEWPORT BEACH, CALIFORNIA, 92660
Covered Properties
(3)
Adenovirus Vectors Containing Heterologous Transcription Regulatory Elements and Methods of Using Same
Patent:
6,432,700 →
Application:
09/033,556 →
Target Cell-Specific Adenoviral Vectors Containing E3 and Methods of Use Thereof
Patent:
6,495,130 →
Application:
09/474,699 →
Target Cell-Specific Adenoviral Vectors Containing E3 and Methods of Use Thereof
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 17, 2001
From: CALYDON, INC
To: CELL GENESYS, INC
Reel/Frame 012243/0012 →
Assignment of Assignor's Interest
Feb 2, 2010
From: CELL GENESYS, INC.
To: BIOSANTE PHARMACEUTICALS, INC.
Reel/Frame 023973/0005 →
Acceptance of Patent Rights
Apr 26, 2011
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 026180/0885 →
Change of Name
Nov 9, 2020
From: COLD GENESYS, INC.
To: CG ONCOLOGY, INC.
Reel/Frame 054362/0411 →